CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Option exercise Director acquired 28,000 shares (option exercise)
- 8-K Event Unregistered share sale · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- 4 Option exercise Chief Financial Officer acquired 35,591 shares (option exercise)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 22 of 45 · 895 filings